Sleep Duration Required to Restore Performance During Chronic Sleep Restriction

Sleep Clinical Trial

Official title:

Sleep Duration Required to Restore Performance During Chronic Sleep Restriction

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01581125
• Other study ID #: NIH R01 HL114088-01
• Status: Completed
• Phase: N/A
• First received: March 22, 2012
• Last updated: July 15, 2016
• Start date: April 2012
• Est. completion date: June 2016

Study information

• Verified date: July 2016
• Source: Brigham and Women's Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to test the hypothesis that sleep and performance depend on length of time awake, length of time asleep, the amount of sleep over several sleep episodes, and circadian phase.

Description:

The purpose of this study is to test the hypothesis that sleep and performance depend on length of time awake, length of time asleep, the amount of sleep over several sleep episodes, and circadian phase. Inpatient sleep and performance data will be collected from healthy volunteers.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 19
• Est. completion date: June 2016
• Est. primary completion date: June 2016
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years to 35 Years

Eligibility

Inclusion Criteria:

• Healthy

Exclusion Criteria:

• Prescription medications

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Basic Science

Related Conditions & MeSH terms

• Insufficient Sleep Syndrome
• Sleep
• Sleep Deprivation

Intervention

Behavioral:
• Sleep:wake 1
Sleep and Wake durations for arm 1
• Sleep:wake 2
Sleep and Wake durations for arm2

Locations

Country	Name	City	State
United States	Brigham and Women's Hospital	Boston	Massachusetts

Sponsors (1)

Lead Sponsor	Collaborator
Brigham and Women's Hospital

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Psychomotor Vigilance Task (PVT) performance	PVT metrics are reaction time. It is measured when the participants are awake during the inpatient portion of the protocol.	PVT during waking for arms 1 and 2 during the 32-day inpatient portion of the protocol	No